Tuesday, December 2, 2014

New targeting Chemotherapies

Eribulin in Breast cancer
Tipiracil in Colon cancer
Ramucirumab and Paclitaxel (or FOLFOX) for Gastric cancer
Panobinostat for Myeloma
Pembrolizumab for lung cancers
Afatinib +chemotherapy for non small cell lung cancers that is EGFR with Mutation Del-19
Bortezomib +chemotherapy VR-CAP for Mantle cell
Nivolumab for Metastatic Renal cancer
anti-BRAF and Anti-MEK for Melanoma

No comments: